Drug Target Review – PublicationsLatest IssueLatest issue Issue #2 2017 Drug Target Review – Issue #2 2017 Issue #2 2017 Review: biomarkers towards personalised therapy in cancer Issue #2 2017 Using native mass spectrometry to inform drug discovery Issue #2 2017 Insights from discovery through clinical efficacy to support a new class of therapeutics in Alzheimer’s disease Issue #2 2017 Screening In-Depth Focus 2017 Issue #2 2017 Stem Cells In-Depth Focus 2017 Issue #2 2017 Targets In-Depth Focus 2017Past IssuesPast Issues Issue #1 2017 Drug Target Review – Issue #1 2017 Issue #4 2016 Drug Target Review – Issue #4 2016 Issue #3 2016 Drug Target Review – Issue #3 2016 Issue #2 2016 Drug Target Review – Issue #2 2016 Issue #1 2016 Drug Target Review – Issue #1 2016 Issue #4 2015 Drug Target Review – Issue #4 2015 Issue #3 2015 Drug Target Review – Issue #3 2015 Issue #2 2015 Drug Target Review – Issue #2 2015 Issue #1 2015 Drug Target Review – Issue #1 2015 Issue #1 2014 Drug Target Review – Issue #1 2014 SupplementsSupplements & Special Editions Issue #2 2017 Targets In-Depth Focus 2017 Issue #2 2017 Stem Cells In-Depth Focus 2017 Issue #2 2017 Screening In-Depth Focus 2017 Issue #1 2017 Assays In-Depth Focus 2017 Issue #1 2017 Biomarkers In-Depth Focus 2017 Issue #1 2017 Antibodies In-Depth Focus 2017 Issue #4 2016 Screening In-Depth Focus 2016 Issue #4 2016 Personalised Medicines In-Depth Focus 2016 Issue #4 2016 Next-Generation Sequencing In-Depth Focus 2016 Issue #3 2016 Imaging In-Depth Focus 2016 Issue #3 2016 Hit-To-Lead In-Depth Focus 2016 Issue #2 2016 Omics In-Depth Focus 2016 Issue #2 2016 Stem Cells In-Depth Focus 2016 Issue #1 2016 Antibodies In-Depth Focus 2016 Issue #1 2016 Assays In-Depth Focus 2016
Issue #2 2017 Insights from discovery through clinical efficacy to support a new class of therapeutics in Alzheimer’s disease
Follow: